Cell Death Discovery (Jan 2022)

ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway

  • Jianbing Hou,
  • Pan Huang,
  • Chao Lan,
  • Shengjun Geng,
  • Minghao Xu,
  • Yudong Liu,
  • Hongbo Chang,
  • Zhongze Wang,
  • Hongyu Gu,
  • Yi Wang,
  • Guang Yang,
  • Hongjuan Cui

DOI
https://doi.org/10.1038/s41420-022-00815-x
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Zinc finger CCCH-type containing 15 (ZC3H15), a highly conserved eukaryotic protein, which was associated with several cellular processes and was ubiquitously expressed in various human tissues. Recent studies indicated that ZC3H15 was involved in tumorigenesis and may be a potential biomarker in hepatocellular carcinoma (HCC) and acute myeloid leukemia (AML). However, the biological function and molecular mechanism of ZC3H15 in gastric cancer (GC) have not been studied. In this study, we revealed that ZC3H15 was highly expressed in GC and high ZC3H15 expression was closely linked to poor survival of patients with GC. We found that ZC3H15 promoted cell proliferation, migration, and invasion by increasing c-Myc expression. Next, we found that ZC3H15 could modulate c-Myc protein stability by suppressing the transcription of FBXW7, which was mainly responsible for c-Myc degradation. Moreover, silencing of FBXW7 in ZC3H15-knockdown GC cells could partly abrogate the effects induced by ZC3H15 downregulation. Taken together, our data unearth the important roles of ZC3H15 in GC development and suggest that ZC3H15 may be a potential target for the treatment of GC.